Vor Biopharma Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vor Biopharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • Vor Biopharma Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.26M, a 28.4% decline year-over-year.
  • Vor Biopharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $10M, a 34.6% decline year-over-year.
  • Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.4M, a 24.9% increase from 2022.
  • Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.7M, a 148% increase from 2021.
  • Vor Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.32M, a 222% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10M $2.26M -$898K -28.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $10.9M $2.79M -$1.45M -34.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $12.4M $3.08M -$987K -24.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $13.4M $1.89M -$1.99M -51.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $15.3M $3.16M -$167K -5.02% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $15.5M $4.24M +$2.5M +143% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $13M $4.07M +$2.32M +133% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $10.7M $3.88M +$2.68M +222% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $8.02M $3.33M +$2.18M +188% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $5.84M $1.74M +$674K +63.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $5.17M $1.75M +$855K +96% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $4.32M $1.2M +$609K +103% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $3.71M $1.15M +$671K +139% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.04M $1.07M +$914K +597% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.12M $891K +$779K +696% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.34M $594K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $483K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $153K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $112K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.